Follow the people · Insider
Christopher A. Kroeger
Christopher A. Kroeger files insider transactions with the SEC as a chief executive officer of MapLight Therapeutics (MPLT). We hold 12 disclosed purchases and sales filed since 11 December 2018, 3 of them in the last 90 days.
- Files forMPLT
- Disclosed buys and sells12 in all, 3 in the last 90 days
- Last disclosure19 August 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 27 October 2025 — 17 August 2026Chief Executive Officer · MapLight Therapeutics (MPLT)41 Form 4 lines · source: SEC Form 4
- Filed 10 May 2018 — 10 May 2018Chief Executive Officer · Millendo Therapeutics (MLND)1 Form 4 line · source: SEC Form 4
Everything they disclosed
42 entries, newest first — one per disclosure report, one per Form 4 line- was granted 23,145 shares of MapLight TherapeuticsSEC Form 419 August 2026Voting Common Stock · traded 17 August 2026 · filed 19 August 2026
- was granted 93,955 shares of MapLight Therapeutics (a derivative holding)SEC Form 419 August 2026Employee Stock Option (right to buy) · traded 17 August 2026 · filed 19 August 2026
- ▼ sold on the open market 18,950 shares of MapLight TherapeuticsSEC Form 417 July 2026Voting Common Stock · traded 15 July 2026 · filed 17 July 2026
- ▼ sold on the open market 42,738 shares of MapLight TherapeuticsSEC Form 417 July 2026Voting Common Stock · traded 15 July 2026 · filed 17 July 2026
- ▼ sold on the open market 90 shares of MapLight TherapeuticsSEC Form 417 July 2026Voting Common Stock · traded 15 July 2026 · filed 17 July 2026
- ▼ sold on the open market 40,899 shares of MapLight TherapeuticsSEC Form 417 July 2026Voting Common Stock · traded 16 July 2026 · filed 17 July 2026
- ▼ sold on the open market 28,091 shares of MapLight TherapeuticsSEC Form 417 July 2026Voting Common Stock · traded 16 July 2026 · filed 17 July 2026
- ▼ sold on the open market 92 shares of MapLight TherapeuticsSEC Form 417 July 2026Voting Common Stock · traded 16 July 2026 · filed 17 July 2026
- ▼ sold on the open market 16,779 shares of MapLight TherapeuticsSEC Form 417 July 2026Voting Common Stock · traded 17 July 2026 · filed 17 July 2026
- ▼ sold on the open market 118,037 shares of MapLight TherapeuticsSEC Form 418 May 2026Voting Common Stock · traded 18 May 2026 · filed 18 May 2026
- ▼ sold on the open market 198 shares of MapLight TherapeuticsSEC Form 418 May 2026Voting Common Stock · traded 18 May 2026 · filed 18 May 2026
- ▼ sold on the open market 14,880 shares of MapLight TherapeuticsSEC Form 411 May 2026Voting Common Stock · traded 7 May 2026 · filed 11 May 2026
- ▼ sold on the open market 5,220 shares of MapLight TherapeuticsSEC Form 411 May 2026Voting Common Stock · traded 7 May 2026 · filed 11 May 2026
- ▼ sold on the open market 29,624 shares of MapLight TherapeuticsSEC Form 411 May 2026Voting Common Stock · traded 8 May 2026 · filed 11 May 2026
- ▼ sold on the open market 1,582 shares of MapLight TherapeuticsSEC Form 411 May 2026Voting Common Stock · traded 8 May 2026 · filed 11 May 2026
- ▼ sold on the open market 3,205 shares of MapLight TherapeuticsSEC Form 411 May 2026Voting Common Stock · traded 8 May 2026 · filed 11 May 2026
- ▼ sold on the open market 342 shares of MapLight TherapeuticsSEC Form 411 May 2026Voting Common Stock · traded 11 May 2026 · filed 11 May 2026
- ▼ sold on the open market 877 shares of MapLight TherapeuticsSEC Form 411 May 2026Voting Common Stock · traded 11 May 2026 · filed 11 May 2026
- ▼ sold on the open market 6,871 shares of MapLight TherapeuticsSEC Form 411 May 2026Voting Common Stock · traded 11 May 2026 · filed 11 May 2026
- ▼ sold on the open market 5,890 shares of MapLight TherapeuticsSEC Form 411 May 2026Voting Common Stock · traded 11 May 2026 · filed 11 May 2026
- ▼ sold on the open market 9,136 shares of MapLight TherapeuticsSEC Form 46 May 2026Voting Common Stock · traded 4 May 2026 · filed 6 May 2026
- ▼ sold on the open market 5,427 shares of MapLight TherapeuticsSEC Form 46 May 2026Voting Common Stock · traded 4 May 2026 · filed 6 May 2026
- ▼ sold on the open market 311 shares of MapLight TherapeuticsSEC Form 46 May 2026Voting Common Stock · traded 4 May 2026 · filed 6 May 2026
- ▼ sold on the open market 697 shares of MapLight TherapeuticsSEC Form 46 May 2026Voting Common Stock · traded 4 May 2026 · filed 6 May 2026
- ▼ sold on the open market 9,544 shares of MapLight TherapeuticsSEC Form 46 May 2026Voting Common Stock · traded 5 May 2026 · filed 6 May 2026
- ▼ sold on the open market 928 shares of MapLight TherapeuticsSEC Form 46 May 2026Voting Common Stock · traded 5 May 2026 · filed 6 May 2026
- ▼ sold on the open market 8,098 shares of MapLight TherapeuticsSEC Form 46 May 2026Voting Common Stock · traded 6 May 2026 · filed 6 May 2026
- ▼ sold on the open market 15,603 shares of MapLight TherapeuticsSEC Form 46 May 2026Voting Common Stock · traded 6 May 2026 · filed 6 May 2026
- ▼ sold on the open market 9,135 shares of MapLight TherapeuticsSEC Form 417 April 2026Voting Common Stock · traded 15 April 2026 · filed 17 April 2026
- ▼ sold on the open market 2,477 shares of MapLight TherapeuticsSEC Form 417 April 2026Voting Common Stock · traded 16 April 2026 · filed 17 April 2026
- ▼ sold on the open market 7,575 shares of MapLight TherapeuticsSEC Form 417 April 2026Voting Common Stock · traded 16 April 2026 · filed 17 April 2026
- was granted 23,145 shares of MapLight TherapeuticsSEC Form 49 February 2026Voting Common Stock · traded 5 February 2026 · filed 9 February 2026
- was granted 93,955 shares of MapLight Therapeutics (a derivative holding)SEC Form 49 February 2026Employee Stock Option (right to buy) · traded 5 February 2026 · filed 9 February 2026
- was granted 93,955 shares of MapLight Therapeutics (a derivative holding)SEC Form 49 February 2026Employee Stock Option (right to buy) · traded 5 February 2026 · filed 9 February 2026
- was granted 23,145 shares of MapLight TherapeuticsSEC Form 49 February 2026Voting Common Stock · traded 5 February 2026 · filed 9 February 2026
- had shares withheld for tax on 204,146 shares of MapLight TherapeuticsSEC Form 429 January 2026Voting Common Stock · traded 27 January 2026 · filed 29 January 2026
- had shares withheld for tax on 204,146 shares of MapLight TherapeuticsSEC Form 429 January 2026Voting Common Stock · traded 27 January 2026 · filed 29 January 2026
- was granted 916,164 shares of MapLight Therapeutics (a derivative holding)SEC Form 428 October 2025Employee Stock Option (right to buy) · traded 27 October 2025 · filed 28 October 2025
- converted 65,477 shares of MapLight Therapeutics (a derivative holding)SEC Form 428 October 2025Series C Preferred Stock · traded 28 October 2025 · filed 28 October 2025
- was granted 225,693 shares of MapLight TherapeuticsSEC Form 428 October 2025Voting Common Stock · traded 27 October 2025 · filed 28 October 2025
- converted 3,895 shares of MapLight TherapeuticsSEC Form 428 October 2025Voting Common Stock · traded 28 October 2025 · filed 28 October 2025
- was granted 47,666 shares of Millendo Therapeutics (a derivative holding)SEC Form 411 December 2018Employee Stock Option (right to buy) · traded 10 May 2018 · filed 11 December 2018
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.